{"id":"autologous-bm-msc","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Infection"}]},"_chembl":{"chemblId":"CHEMBL4802046","moleculeType":"Unknown","molecularWeight":"502.55"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"BM MSCs are multipotent cells capable of differentiating into various cell types and secreting immunomodulatory and anti-inflammatory factors. When reintroduced into the patient, they promote tissue regeneration, reduce inflammation, and support healing through paracrine effects and direct cellular replacement. This autologous approach minimizes rejection risk while leveraging the cells' inherent regenerative and immunoregulatory properties.","oneSentence":"Autologous bone marrow-derived mesenchymal stem cells (BM MSCs) are harvested from the patient's own bone marrow and administered to promote tissue repair and modulate immune responses.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:02:57.235Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05095532","phase":"PHASE1","title":"Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2021-12-01","conditions":"Chronic Pancreatitis, Mesenchymal Stem Cells","enrollment":42},{"nctId":"NCT05080465","phase":"PHASE3","title":"Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis","status":"COMPLETED","sponsor":"Ukraine Association of Biobank","startDate":"2018-12-02","conditions":"Liver Cirrhosis","enrollment":700},{"nctId":"NCT05066334","phase":"PHASE2","title":"Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Campus Bio-Medico","startDate":"2021-03-22","conditions":"Intervertebral Disc Degeneration, Chronic Low-back Pain","enrollment":52},{"nctId":"NCT04759105","phase":"PHASE2","title":"Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Campus Bio-Medico","startDate":"2019-11-03","conditions":"Intervertebral Disc Degeneration, Chronic Low-back Pain","enrollment":48},{"nctId":"NCT04815213","phase":"PHASE1","title":"The Use of Expandeded Mesenchymal Stromal Cells (MSC) in Premature Ovarian Failure (POF) in Adult Humans","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Jordan","startDate":"2022-01-01","conditions":"Premature Ovarian Failure","enrollment":10},{"nctId":"NCT03325504","phase":"PHASE3","title":"A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union","status":"COMPLETED","sponsor":"Universidad Autonoma de Madrid","startDate":"2017-09-05","conditions":"Non Union Fracture","enrollment":46},{"nctId":"NCT03626090","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cell Therapy for Liver Cirrhosis","status":"UNKNOWN","sponsor":"Stem Med Pte. Ltd.","startDate":"2018-08-18","conditions":"Liver Cirrhosis","enrollment":20},{"nctId":"NCT02566655","phase":"PHASE1","title":"Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis","status":"COMPLETED","sponsor":"Red de Terapia Celular","startDate":"2015-09","conditions":"Osteoporosis, Spinal Fractures","enrollment":10},{"nctId":"NCT02057965","phase":"PHASE2","title":"Mesenchymal Stromal Cell Therapy in Renal Recipients","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2014-03","conditions":"Renal Transplant Rejection, Fibrosis","enrollment":70},{"nctId":"NCT04545307","phase":"PHASE2, PHASE3","title":"Transplantation of Allogeneic MSC in Patients With Pulp Necrosis and Chronic Apical Periodontitis","status":"COMPLETED","sponsor":"Universidad Central de Venezuela","startDate":"2019-11-27","conditions":"Pulp Necroses, Apical Periodontitis","enrollment":5},{"nctId":"NCT04501341","phase":"PHASE1, PHASE2","title":"BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2016-03-14","conditions":"T2D","enrollment":15},{"nctId":"NCT02323477","phase":"PHASE1, PHASE2","title":"Human Umbilical Cord Stroma MSC in Myocardial Infarction","status":"TERMINATED","sponsor":"Ankara University","startDate":"2015-02-02","conditions":"Chronic Ischemic Cardiomyopathy, Coronary Artery Bypass Surgery","enrollment":46},{"nctId":"NCT02981576","phase":"PHASE1, PHASE2","title":"Safety and Effectiveness of BM-MSC vs AT-MSC in the Treatment of SCI Patients.","status":"COMPLETED","sponsor":"University of Jordan","startDate":"2016-11","conditions":"Spinal Cord Injuries","enrollment":14},{"nctId":"NCT03943940","phase":"PHASE1, PHASE2","title":"BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients","status":"UNKNOWN","sponsor":"Van Hanh General Hospital","startDate":"2019-04-24","conditions":"Type 2 Diabetes Mellitus","enrollment":60},{"nctId":"NCT03484741","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cell Therapy for Type 1 Diabetes Mellitus Patients","status":"UNKNOWN","sponsor":"Van Hanh General Hospital","startDate":"2017-04-01","conditions":"Type 1 Diabetes Mellitus","enrollment":15},{"nctId":"NCT02646007","phase":"PHASE1","title":"Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation(BM-MSC) for Kienbock's Disease","status":"UNKNOWN","sponsor":"Royan Institute","startDate":"2015-11","conditions":"Kienböck's Disease","enrollment":30},{"nctId":"NCT02195323","phase":"PHASE1","title":"Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2014-04","conditions":"Chronic Kidney Disease","enrollment":7},{"nctId":"NCT02448849","phase":"PHASE2, PHASE3","title":"Autologous BM-MSC Transplantation in Combination With Platelet Lysate (PL) for Nonunion Treatment","status":"UNKNOWN","sponsor":"Royan Institute","startDate":"2015-06","conditions":"Bone Fracture","enrollment":60},{"nctId":"NCT01456819","phase":"PHASE2","title":"Intramuscular Mononuclear Cells and Mesenchymal Stem Cells Transplantation to Treat Chronic Critical Limb Ischemia","status":"UNKNOWN","sponsor":"National University of Malaysia","startDate":"2011-03","conditions":"Critical Limb Ischemia","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Autologous BM MSC","genericName":"Autologous BM MSC","companyName":"Stem Med Pte. Ltd.","companyId":"stem-med-pte-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":false,"safety":true,"trials":true,"score":3}}